Approval · Notice of Compliance 797 · 2003
LYDERM OINTMENT: Notice of Compliance 797
Issued September 4, 2003
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 797
- Date
- September 4, 2003
- Company
- Taropharma, A Division Of Taro Pharmaceuticals Inc.Brampton, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Abbreviated New Drug Submission (ANDS)
- Submission class
- Admin
- Reason
- Manufacturer name change
- Therapeutic class
- Topical corticosteroid
- Canadian reference product
- LIDEX OINTMENT, TOPSYN GEL
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| LYDERM OINTMENT | 02236996 | Marketed |
| LYDERM GEL | 02236997 | Marketed |
Medicinal ingredients
- FLUOCINONIDE 0.05 PER